NCT05569291 (LUCA-coach) is a NA clinical trial of Automated Coaching Program (ACP) in Non-small Cell Lung Cancer, sponsored by Hasselt University.

Who is sponsoring NCT05569291?

NCT05569291 is sponsored by Hasselt University.

What drugs are being tested in NCT05569291?

Interventions in NCT05569291: Automated Coaching Program (ACP), Manual Coaching Program (MCP).

What condition does NCT05569291 study?

NCT05569291 studies Non-small Cell Lung Cancer, Non-small Cell Carcinoma.

Is NCT05569291 still recruiting?

NCT05569291 is currently completed. Last updated 4 October 2024.

Last reviewed 2024-10-04 · How we verify

NCT05569291: LUCA-coach

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study

Completed NA Last updated 4 October 2024

What this trial tests

NA trial testing Automated Coaching Program (ACP) in Non-small Cell Lung Cancer in 19 participants. Completed in 1 December 2023.

Timeline

1 October 2022

Primary endpoint
1 December 2023

1 December 2023

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	19
Start date	1 October 2022
Primary completion	1 December 2023
Estimated completion	1 December 2023
Sites	2 locations across Belgium

Drugs / interventions tested

Automated Coaching Program (ACP)
Manual Coaching Program (MCP)

Conditions studied

Non-small Cell Lung Cancer — all drugs for Non-small Cell Lung Cancer →
Non-small Cell Carcinoma — all drugs for Non-small Cell Carcinoma →

Sponsor

Hasselt University

Who can join

45 and older, any sex, with Non-small Cell Lung Cancer or Non-small Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the acceptability, actual usage, feasibility and safety of 1) a (semi) automated PA tele coaching intervention including smartphone application and stepcounter (Fitbit Charge 4) and 2) a manual PA tele coaching program using only a stepcounter (Fitbit Charge 4) without custom smartphone application but still linked with a smartphone using the Fitbit application and to make population specific adaptations to the intervention for patients with NSCLC after lung resection surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Non-small Cell Lung Cancer

Currently open trials in the same condition.

NCT07431827 — MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) · Phase 3 · recruiting
NCT05987956 — Pharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms · Phase 2, PHASE3 · active not recruiting
NCT07195695 — Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer Wit · Phase 3 · recruiting
NCT06686771 — Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer · Phase 3 · recruiting
NCT06477055 — The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer · recruiting

Other Hasselt University trials

Trials by the same sponsor.

NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05569291 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasselt University
Last refreshed: 4 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05569291.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing